There are very few reports about complete-blood-count (CBC) findings in paediatric tuberculosis. We assessed the prevalence and predictors of haematologic abnormalities and the utility of a routine CBC in initial management of paediatric TB. We reviewed records and results of investigations of all children and adolescents (ages 0-18) treated for TB disease at the Hospital
Introduction
A complete-blood-count (CBC) is often performed during the course of management of disease in children, but there are few data about findings in children with suspected tuberculosis (TB) especially from a high-income setting. Haematologic abnormalities occurring in adult TB patients in a high-TB burden low income country have been associated with disease severity and response to treatment [1] .
We sought to document the prevalence and predictors of haematologic abnormalities in children and adolescents diagnosed with TB and to assess the utility of a routine CBC in management of paediatric TB.
Materials and Methods
We retrospectively reviewed records of all patients aged 0-18 years with TB disease diagnosed and managed at the Hospital for Sick Children, Toronto (SickKids), from January 2002 to December 2012. The SickKids TB program is used by public health units and clinicians in the greater Toronto area as the principal centre for evaluation and management of paediatric TB. All patients followed by the program during this period had detailed demographic and clinical data prospectively recorded at first clinic visit on a standardized form. Patients were followed monthly until treatment completion with no loss to follow up during the study period. Initial and follow-up complete-blood-counts were ordered at the discretion of the treating clinician.
Data collected in a standardized data collection sheet included age, gender, weight-for-age percentile, pre-existing comorbid conditions and medications, and results of the CBC and iron studies. Anaemia and severe anaemia were defined using World Health Organization reference values [2] and other haematologic and biochemical abnormalities according to hospital laboratory age-based reference values [3] . Weightfor-age percentiles were calculated using World Health Organization (WHO) Growth Charts for Canada [4] .
TB disease was characterized as laboratory-confirmed or probable and by site of disease. Pulmonary involvement or intrathoracic lymphadenopathy without involvement of other sites was classified as pulmonary TB. Extrapulmonary TB that was confined to one site or included two contiguous sites (including pulmonary plus pleural involvement) was classified as non-disseminated extrapulmonary TB. Disseminated disease was defined as occurrence of disease in 2 or more noncontiguous sites. During the period of the study, the diagnosis of TB disease was established using standard case definition and was managed using standardized protocols [5, 6] . Patients who did not have a CBC within the 2 weeks before treatment initiation were excluded. The study was approved by the research ethics board at the Hospital for Sick Children (REB# 1000047992).
Analysis: Descriptive statistics are reported as median and interquartile ranges for continuous variables and as percentages for categorical variables. Potential predictors of abnormalities were analysed by univariate logistic regression: variables found significant were subjected to multiple variable logistic regression. Analysis was performed using SAS software (SAS version 9.4, Cary, North Carolina, USA).
Results
Of the 161 patients who were treated for TB disease, 138 who had a CBC within 2 weeks before treatment were included. Excluded patients (n = 23) were more likely to have isolated pulmonary disease; and less likely to have microbiologically proven disease (Supplementary Table 1 ). Of the included patients, the median age was 12.2 years (IQR 5.3-15.4 years). The weight-for-age was < 5th percentile in 25 (18%) cases. Eighty-three (60%) cases had microbiologically proven TB. Disease was exclusively pulmonary in 86 (62.3%) and disseminated in 18 (13.0%). Extrapulmonary TB that was not disseminated was diagnosed in 34 (24.6%) children: 15 (41.2%) had tuberculous lymphadenitis, 3 (8.8%) TB meningitis, 2 (6.9%) abdominal TB and 14 (44.1%) had other sites involved. HIV status was known in 114 (82.6%) cases: all were seronegative.
Anaemia was the most common haematologic abnormality occurring in 58 (42%) cases (Table 1) : of these, anaemia was moderate to severe in 30/58 (52%). It was normocytic normochromic in 18 (31%) and microcytic in 40 (69%) cases with normochromia or hypochromia. Six cases had comorbidities associated with anaemia (Table 1 ) and were excluded from further analysis of anaemia. When these cases were excluded, anaemia was present in 39% of cases and was moderate to severe in 50% of these (Supplementary Table 2 ). On univariate analysis anaemia was more likely in those with disseminated TB, in females > 15 years of age and in those with weight-for-age < 5th percentile ( Table 2 ). On multiple variable logistic regression anaemia was more likely with disseminated TB (OR 3.55 [95% CI 1.10-11.47] p = 0.034) and Of patients with microcytic anaemia, 14 had iron studies within first 4 weeks of treatment. Four had normal iron, ferritin and transferrin levels. The other 10, all had low serum iron, transferrin was high (n = 2), normal (n = 4), low (n = 3) and not done in one. Iron studies were done in five of those who had normocytic normochromic anaemia: one patient had a low serum iron, and others had normal iron and transferrin (n = 4). Oral iron was prescribed for 4 patients within 4 weeks of the initial CBC: 2 patients with microcytic anaemia without complete confirmatory iron studies and 2 young children who were breastfed with poor solid intake (Supplementary Table 3 ). Iron therapy was later initiated in 4 patients because anaemia developed during treatment. In one patient with multidrug-resistant TB, oral iron therapy induced marked gastrointestinal intolerance of all drugs leading to a 6-day interruption of therapy (Supplementary Table 3 ).
All patients were followed to completion of antituberculous treatment. After the 6 patients who had comorbidities associated with anaemia and 8 who received iron therapy were excluded, 27 (61%) of the remaining 44 patients with anaemia had repeat CBCs during or immediately after TB therapy, and all of them had resolution of the anaemia. The mean increase in haemoglobin was 22.6 g/L (Range 7-41 g). The normal haemoglobin values were obtained in a median period of 75 days (IQR 46-156) and 105 days (IQR 59-141) for mild anaemia and moderate-severe anaemia, respectively.
One-hundred and twenty-four patients had differential white cell counts ( Supplementary Table 4 ). Lymphopenia was found in 30 patients (24.2%), all of whom were HIVnegative, and was more common in patients aged > 15 years (OR 6.8 95% CI [2.8-16.7] p = 0.0001). There was no significant difference in disease site and occurrence of lymphopenia. Lymphopenia < 1.0 × 10 9 /L occurred in 5 cases.
Neutrophilia was found in 20/124 (16%) patients: 9 with pulmonary TB, 6 with disseminated and 5 with extrapulmonary TB. Of the nine cases of pulmonary TB with neutrophilia, 6 (5 microbiologically confirmed) had lobar airspace disease. For the 9 patients with pulmonary TB and neutrophilia, the median was neutrophil to lymphocyte count ratio was 3.3 (Range 1.8-9.4); in 2/9 (22%) the ratio was greater than 7 (both > 9). Neutropenia was seen in 4/124 (3.2%); in no case was severe neutropenia found at presentation.
One patient had thrombocytopenia, a 3-month-old with disseminated TB. A platelet count above 400 × 10 9 /L was found in 50/138 (36.2%) of patients and was greater than 500 × 10 9 /L in 20/138(14%). A platelet count > 400 × 10 9 /L was significantly associated with the presence of anaemia (OR 4.3 [95%CI 1.6-11.9] p < 0.004), occurring in 15/58 (26%) patients with anaemia and 6/80 (8%) with no anaemia but was not significantly related to disease site.
Discussion
This study describes haematologic parameters at presentation in children diagnosed with TB in a developed country where baseline haematologic findings are less likely to be influenced by malnutrition, parasitic disease and recurrent infections.
We found anaemia was common in children and adolescents with TB, was often moderate to severe and was more common in those with disseminated disease and adolescent females. The 42% incidence of anaemia in our study compares with 48% in a South African study of children with TB [7] , and rates of 16% to 94% in studies of adults [8, 9] . For those with repeat CBCs, the anaemia resolved during anti- tuberculous therapy alone suggesting that it reflected the anaemia of chronic inflammation. Anaemia associated with chronic diseases results from dysregulation of iron haemostasis and is characteristically normochromic, normocytic and mild-to-moderate in severity [10] . In a study of adult TB patients, 72% of the anaemia was normocytic [ 8] , whereas most (69%) anaemia in our study was microcytic. The raised ferritin and low-to-normal transferrin values found in most of our patients who had iron studies is in keeping with anaemia of inflammation, although in some cases iron deficiency may have contributed. Iron therapy may cause gastrointestinal intolerance and interfere with administration of anti-tuberculous drugs, and its introduction led to interruption of TB therapy in a patient in this series: it is important that clinicians recognize that in the context of highincome country, iron therapy is usually not needed in the initial management of paediatric patients with TB and microcytic anaemia. The finding of an increased prevalence of anaemia in adolescent girls is likely due to an association with menstrual blood loss [11] which may have compounded the other factors. We did not assess a menstrual history in this retrospective study, and this information was not reliably available from the records.
The white cell abnormalities that were found did not change management but might lead to consideration of alternative diagnoses. Lymphopenia was found in 24% of patients and was more common in adolescents: this compares with a lymphopenia rate of 46% in a study of adult TB patients [12] . Lymphopenia may raise concern for HIV coinfection, but all our lymphopenic patients were HIV negative. Mycobacterium tuberculosis infection has been associated with a reduction in expression of genes regulating T cell proliferation which may partly explain the finding [13] . Neutrophilia occurred in patients with microbiologically proven pulmonary TB disease including those with lobar airspace disease illustrating that neutrophilia is nonspecific and does not necessarily imply bacterial pneumonia. One study in adults found that a neutrophil-lymphocyte count ratio of less than 7 differentiated TB from bacterial pneumonia with 91% specificity [14] ; however, while the median ratio for the 9 patients with pulmonary TB in our study was 3.3, two patients had ratios greater than 7; both of these ratios were greater than 9.
Finally, a routine CBC had very limited utility in the management of our patients: in 4 cases, management was changed by the prescription of oral iron, but iron deficiency was conclusively diagnosed in only one of these children. In 2 instances, a microcytic anaemia alone prompted treatment. Confining evaluation to those with disseminated disease and adolescent females would have captured almost all patients who may have required iron therapy. These data may especially have implications for resource poor settings.
This study has several limitations. It examined a cohort diagnosed with TB rather than patients being evaluated for possible TB and compared values found to normal values rather than values from a suitable control group and so provides very limited information about the utility of the CBC as a diagnostic test. It is retrospective, and CBCs were not obtained on all patients. Biochemical indicators of iron deficiency were obtained in a minority of patients. Follow-up blood counts were not obtained on several patients who had anaemia. It was performed in a low TB burden and well-resourced setting and may not be applicable to other settings where TB is more prevalent. Nonetheless, our data shows that anaemia is common in children and adolescents with TB, frequently responds to anti-tuberculous treatment alone and seldom requires iron therapy; that white cell count abnormalities found are nonspecific and that a routine initial CBC has very limited utility in the management of patients with paediatric TB.
